| Name | Title | Contact Details |
|---|
Statim is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wright and Filippis is a Rochester Hls, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For nearly 50 years, Acts Retirement-Life Communities has met the retirement lifestyle and healthcare needs of older adults living in our communities. Our first community opened in 1972 with the vision of a church pastor and his congregation whose goal was to create an environment that offered seniors a rewarding lifestyle and high quality healthcare if ever needed. Today, Acts is the largest not-for-profit owner, operator and developer of continuing care retirement communities (CCRCs) in the United States. Our 26 communities currently serve more than 10,000 residents in nine states. Our vision for Acts is to have The Acts Culture of Loving-Kindness be the basic fiber of our daily practice to meet the needs of those we serve. As we continue to grow, we`re looking for dedicated and compassionate individuals to join our team who help to carry out our mission of serving older adults. We have been able to provide an unparalleled quality of life for our residents by recruiting and hiring great people who understand our vision and strive to be a part of it. We are convinced that the secret to our success is our employees who work as a team each day to make a positive difference in the lives of our residents. It is for this reason that we provide a working environment based on fair employment practices, competitive pay and benefits, career opportunities and other programs designed to help our employee`s achieve their professional goals.
Instruments for Thoratic, Cardio Vascular, Neuro /Spine, Orthopeadic and General Surgery.
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.